Making Space for Anti-Infective Drug Discovery
Author:
Publisher
Elsevier BV
Subject
Virology,Microbiology,Parasitology
Reference15 articles.
1. The Health Impact Fund: incentives for improving access to medicines
2. Type IIA topoisomerase inhibition by a new class of antibacterial agents
3. The art and practice of structure-based drug design: A molecular modeling perspective
4. Targeting virulence: a new paradigm for antimicrobial therapy
5. Duffy, N.P. June 2010. U.S. patent 2010-0161531 A1.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Biology of antimicrobial resistance and approaches to combat it;Science Translational Medicine;2020-06-24
2. Does global drug innovation correspond to burden of disease? The neglected diseases in developed and developing countries;Health Economics;2018-11-12
3. Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?;Current Topics in Medicinal Chemistry;2018-10-04
4. Targeting the Proteostasis Network for Mycobacterial Drug Discovery;ACS Infectious Diseases;2018-02-21
5. Phenotypic Tolerance and Bacterial Persistence;Antimicrobial Resistance in the 21st Century;2018
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3